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Spheroids from equine amnion mesenchymal stem cells: an in vitro 
study
Alessandra Colia, Maria Rita Stornellia, Francesca Nocchib, Roberta Lamannab, Mariacarla Ioriob, Simone Lapib, 
Patrizia Urciuolib, Carla Lenzia, Elisabetta Giannessia
INTRODUCTION
Equine mesenchymal stem cells (EMSCs) were isolated from 
bone marrow [1-4], adipose tissue [5], peripheral blood [1] and 
cord blood [6,7]. Currently, there is an increasing interest in 
the investigation of adult extra-embryonic tissues such as fetal 
adnexa (amnion, amniotic fl uid and Wharton jelly) [8-10] due 
to easy collection aft er birth of the foal.
Hoyonowski et al. [11] fi rst isolated and characterized 
mesenchymal stem cells from equine umbilical cord matrix 
(Wharton’s jelly) with an embryonic phenotype (Oct-4, C-kit) 
and an ability of osteogenic, chondrogenic and adipogenic 
diff erentiation. Among the equine fetal adnexa, the amnion has 
been recently studied as an alternative source of mesenchymal 
cells used in the fi eld of equine regenerative medicine. Th e 
amnion is a thin membrane, which forms the wall of a fl uid-fi lled 
sac in which the embryo develops. In mammals, the amnion 
is derived from the inner somatopleure membrane, which 
remains attached to the embryo at the umbilicus. In literature, it 
is reported that mesenchymal cells can be isolated from amnion. 
Th ey express stem cell surface markers such as embryonic 
stem cells and are doubly negative for MHC I and MHC II 
[12]. Th ey can diff erentiate into ectodermal and endodermal 
lineages once isolated and grown in special culture media [13]. 
Th ese cell populations display a fi broblast-like appearance, 
adhere onto plastic culture vessels, form clonal colonies and 
under appropriate culture conditions, they diff erentiate into 
adipocytes, osteocytes, chondrocytes and neuronal cells [14-
17]. Th erefore, these cells represent a potential use in cellular 
therapy and regenerative medicine applications. Th e Authors 
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Background: Equine amnion mesenchymal stem cells (EAMSCs) from amnion isolated aft er 
the foal birth represented an alternative source of easy collection of mesenchymal cells used in 
equine regenerative medicine.
Materials and Methods: Th ese cells grown as two-dimensional (2-D) culture in alpha modifi ed 
minimum essential medium supplemented with epidermal growth factor were diff erentiated in 
adipogenic, chondrogenic, and osteogenic cells. Half a million cells as pellet were left  in 15 ml 
tubes with the same diff erentiation media for 20 days. Aft er the pellets were collected, embedded 
in paraffi  n for morphological study.
Results: 2-D culture showed EAMSCs with an embryonic phenotype (C-kit+, CD105+, Oct-4+) 
and a diff erentiation potential in adipogenic, chondrogenic and osteogenic multipotent cells. By 
a reproducible method of three-dimensional (3-D) culture, at day 20 the Authors evidenced a 
formation of small aggregated spheroids gradually gathering. In cross sections, the surface of the 
spheroid evidenced fl attened cells embedded in a red matrix by Alizarin staining and occasionally 
a core of calcium precipitation. A network of apoptotic or necrotic cells in a not mineralized 
matrix was present into the center of nodules. Th e 3-D spheroids appeared larger (mean diameter 
of 605 ± 53 μm for gathering spheroids and 1486 ± 79 μm for spheroids already gathered) than 
those from standard monolayer cultures (mean diameter of 200 ± 73 μm).
Conclusions: EAMSCs cultured in 3D method preserve their in vitro multipotent diff erentiation 
than adherent 2-D culture method. Th ese EAMSCs included in the extracellular matrix not 
mineralized at day 20 seem to be a good source of MSCs for tissue repair and regeneration in 
equine medicine.
Keywords: Equine, Amnion, Mesenchymal stem cells, Cell culture, Spheroid, 
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have already performed a procedure of expanding equine 
amnion mesenchymal stem cells (EAMSCs) by a non-invasive 
technique for the isolation of the cells and used culture media 
supplemented with epidermal growth factor (EGF) [15,16].
In addition to traditional two-dimensional (2-D) culture 
methods in which the mesenchymal stem cells grow in a 
single layer, in recent years many authors suggest the use of 
three-dimensional (3-D) culture. As the plastic surface limits 
the potential of stem cells to recreate in-vivo conditions [18], 
aggregates of cells grown in suspension culture and showing 
a spheroid shape are reported. Th ey can be embedded in 
scaff olds [19-22] or cultivated scaff old-free [23,24] though it is 
reported that a synthetic material may represent a limitation to 
the cell-cell interactions [25,26].
Th ese spheroids (“mesenspheres”) show a physiological 
microenvironment in which cell-cell or cell-scaff old interactions 
are better achieved than in monolayer culture methods [23,27]. 
If grown in appropriated culture media, these spheroids exhibit 
chondrogenic, adipogenic and osteogenic competence and an 
enhanced secretion of tropic factors [28-30].
Objective
Th e aim of this study is to perform an effi  cient and 
reproducible method for the isolation of EAMSCs and their 
diff erentiation into spheroids, reporting on adipogenic, 
chondrogenic and osteogenic diff erentiation in terms of 
morphological and morphometrical point of view, in order 
to obtain a biological source with potential clinical use in 
regenerative medicine of horses.
MATERIALS AND METHODS
Amnion cells were obtained from 4 10 to 13  years old 
standardbred mares as previously described [16]. For the study 
of cellular stemness, immunocytochemistry on amnion sections 
with anti-C-Kit, -CD105 and -Oct-4 antibodies, involved self-
renewal of embryonic stem cells, was performed as reported 
above [16]. Amnion samples, washed in phosphate-buff ered 
saline (PBS) solution (Euroclone, MI, Italy) and soaked in 
10 mL of a collagenase solution (1 mg/mL) for 30 min at 37°C, 
were suspended and fi ltered through a 100 mm fi lter (Millipore, 
Billerica, MA, USA).
2-D Cell Culture
Nucleated cells isolated by gradient centrifugation (500  g 
for 10  min) were resuspended in Alpha modifi ed minimum 
essential medium (α-MEM) (Cambrex, NJ, USA) with 10% fetal 
bovine serum (Eurobio, France), 10% horse serum (HS), 100 
U/mL penicillin, 100 μg/mL streptomycin, 2 mM L-glutamine 
(Euroclone, MI, Italy) and 10 ng/ml EGF (Sigma). Cells were 
cultured at 105  cells/cm2 and the adherent ones were grown 
in fresh medium for about 14  days, until 90% of confl uence 
(Passage 0, or P0). For further expansion (Passage  1, or P1) 
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the cells were then sub-cultured (by 0.25% trypsin in 1 mM 
ethylenediaminetetraacetic acid [EDTA]) (Euroclone, Milan, 
Italy) for 5 min at 37°C, replated at 5000 cells/cm2 and harvested 
with the same protocol.
3-D Cell Culture
Half a million cells were dissociated with 0.25% trypsin in 1 
mM EDTA (Euroclone, Milan, Italy), centrifuged at 1000 rpm 
for 5 min and the pellet was left  in 15 ml tubes in a rotary shaker 
in an incubator with the diff erentiation media (adipogenic, 
chondrogenic and osteogenic media) for 20 days. Every 3 days, 
the tubes with the cells were centrifuged at 1000 rpm for 5 min, 
the supernatant removed and replaced with fresh medium. 
Aft er 20 days, the pellets were collected and washed in PBS.
Flow Cytometric Study
Analysis was performed, as mentioned above, [16] using 
anti-MHC I (Serotec, Oxford, UK), anti-MHC II (Serotec), anti-
CD14 (Serotec), anti-CD45 (Serotec), anti-CD44 (Chemicon, 
Temecula, CA, U.S.A.), anti-b-1-integrin (Chemicon) and 
anti-CD90 (Santa Cruz Biotechnology, Santa Cruz, CA, U.S.A.) 
mouse monoclonal antibodies. As secondary antibody, an FITC 
goat anti-mouse IgG (Santa Cruz Biotechnology) was used. 
A minimum of 10.000 events was acquired for each sample.
Diff erentiation protocols
Adipogenic medium: a-MEM supplemented with 10% FCS 
and 10% HS, 100 U/mL Penicillin, 100 μg/mL Streptomycin, 12 
mM L-glutamine, 5μg/mL insulin (Lilly), 50μM indomethacin 
(Sigma), 1 mM dexamethasone (Sigma, St.Louis, MO, U.S.A.) 
and 0.5 μM 3-isobutyl-1-methylxanthine (IBMX, Sigma, 
St.Louis, MO, U.S.A.) for 2 weeks.
Chondrogenic medium: Chondrocyte basal medium 
(Cambrex Bio Science, Walkersville, MD, U.S.A.) for 3 weeks.
Osteogenic medium: a-MEM supplemented with 10% FCS 
and 10% HS, 100 U/mL penicillin, 100  μg/mL streptomycin, 
2 mM L-glutamine, 20 mM b-glycerol phosphate (Sigma, 
St.Louis, MO, U.S.A), 100 nM dexamethasone (Sigma, St.Louis, 
MO, U.S.A.) and 250μM ascorbate 2-phosphate (Sigma, 
St.Louis, MO, U.S.A) for 3 weeks.
Histology
Cell monolayer (2-D cell culture) was fi xed in 10% formalin 
for 20  min at RT and stained with 0.5% Oil Red O (Sigma, 
St. Louis, MO, U.S.A.) in methanol (Sigma) for 20 min at RT, 
Alcian Blue solution (Sigma, St. Louis, MO, U.S.A.) pH 2.5 for 
20  min at RT (cell nuclei counterstained with Weigert’s iron 
hematoxylin) and Alizarin Red (Sigma, St. Louis, MO, U.S.A.) 
pH 4.1 for 20 min at RT.
Th e spheroids from 3-D culture were fi xed in 10% formalin 
for 20  min at reverse transcription (RT) and embedded in 
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paraffi  n. Th ey were sectioned at 4 μ, made permeable with 
methanol for 2 min at RT and washed 3 times with PBS. Th e 
sections were processed by Alizarin Red and by double staining 
(Alcian blue and Alizarin Red).
Morphometry
Th e size of spheroids was measured by Nikon Digital Sight 
DS-U1 Program (Nikon)
RESULTS
Amnion sections showed positivity for C-Kit, CD105 
and Oct-4 antigens, markers of stemness (Figure 1). 
Cytofl uorimetric analysis of EAMSCs showed cells positive to 
CD 90, CD 44, CD 14 and CD 45.
In 2-D cell culture adipogenic diff erentiation showed 
rounded cells staining positive with Oil Red O, with 
lipid vesicles in the cytoplasm increasing in amount over 
time (Figure 2a). Chondrogenic diff erentiation showed 
glycosaminoglycans in the matrix aft er alcian blue staining 
(Figure 2b). With osteogenic diff erentiation, from the 5th day of 
cell culture, the Authors observed bone nodules (200 ± 73 μm 
of mean diameter) with a layer of epithelium-like fi broblastoid 
cells around, close to each other, more elongated and fl attened 
(Figure 2c and d).
Histological analyses of 3-D cell culture (Figure 3) aft er 
20  days of culture showed nodules aggregated in small 
spheroids that gradually gathered into a single one (Figure 3a). 
Epithelial cells of spheroid surface, embedded in a red matrix by 
Alizarin staining, were observed. In every single small nodule 
it was possible to observe epithelium-like fi broblastoid cells 
and a network of apoptotic or necrotic cells embedded into a 
AQ6
Figure 3: Equine amnion mesenchymal stem cells diff erentiation in 
3-D culture spheroid sections: Alizarin red (a, b and d); alcian blue 
and alizarin red (c)
a b
c d
Figure 2: EAMSCs in 2-D culture: adipogenic (oil red O) (a), 
chondrogenic (alcian blue) (b) and osteogenic (alizarin red) (c and d) 
diff erentiation
b
c d
a
Figure 1: Immunohistochemical study: C-Kit (a), CD105 (b) and Oct-
4 (c) antigens
a
b
c
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non-mineralized matrix, organized in circular or ovoid areas, 
positive to Alcian blue staining, (Figure 3b and c). Where the 
matrix was mineralized, it was possible to highlight a core of 
calcium precipitation (Figure 3d). Th e 3-D spheroids appeared 
larger than those from standard monolayer cultures: Th eir 
mean diameter ranged from 605 ± 53 μm for single spheroids 
getting together to 1486 ± 79 μm for spheroids already gathered 
in a single one.
DISCUSSION
In the literature are present studies about equine 
mesenchymal cells from other sources but not from 
amnion [6,10]. Th e EAMSCs were investigated for their possible 
use in cell therapy because of non-invasive techniques for cell 
extraction; indeed, it was easy to sample amnion immediately 
aft er birth because the colt come off  the chorion and the mare 
second the rest of the placenta later. Bacterial and fungal 
contamination represented the main problem to be settled, due 
to the environment where the procedure of amnion sampling 
was performed. For this purpose we used a sampling protocol 
employed in our previous study [15] Cytofl uorimetric analysis 
showed a phenotype of mesenchymal stem cells, confi rming 
the positivity of stemness antigens and thus their pluripotency.
When grown in specifi c culture media, EAMSCs 
diff erentiated into adipogenic, chondrogenic and osteogenic 
lineages. Th e eff ects of the addition of EGF in the culture 
medium did not aff ect their ability to diff erentiate [15]. Th is 
study developed a technique for sampling, isolation and 
expansion of EAMSCs for producing a 3-D cell culture system. 
Th e method of aggregation for EAMSCs spheroid formation 
yielded largely homogeneous spheroids, which might be 
maintained for a longer time (20 days) in suspension by rotary 
shaking. Under chondrogenic conditions the Authors showed 
the presence of glycosaminoglycans as blue deposits immersed 
in a network of fi broblastoid cells, as reported in literature 
for bovine umbilical cord [24] but of larger diameter for they 
gathered in a single spheroid. Under osteogenic conditions 
a signifi cant positive staining of fl attened cells suggesting 
their osteogenic diff erentiation was observed, even if the 
mineralization of nodule matrix was not complete at 20 days 
(as reported by double staining). By both of the staining 
methods, the Authors observed changes in cell morphology, 
especially for the cells embedded in the matrix, referred to as 
diff erent replicative ability [18]. From literature, 3-D cell culture 
systems allowed a more physiological environment for stem 
cells survival in contrast to adherent monolayer; cell-cell and 
cell-matrix interactions improved. Th e matrix mineralization 
increased until day 14 of osteogenic diff erentiation for murine 
bone marrow-derived MSCs [23] and until day 10 for human 
bone marrow-derived MSCs [22]
CONCLUSIONS
Our data showed that at 20 days of osteogenic diff erentiation 
matrix mineralization is not yet complete (extracellular matrix 
AQ6
was positive to alcian staining and negative to alizarin red 
staining). Th e Authors referred this diff erence to the embryonic 
origin of these cells; their self-renewal and high potential of 
sub-culturing in vitro might be greater than adult MSCs. Th is 
study confi rmed the successful development of 3-D culture 
method for EAMSCs in preserving their in-vitro multi-potent 
diff erentiation than the adherent 2-D culture method. Th ese 
results might provide a basis for the establishment of a database 
for collecting and preserving EAMSCs to be used for equine 
regenerative medicine.
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